Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.

M Mannucci, P; T Canciani, M; Rota, L; S Donovan, B

doi:10.1111/j.1365-2141.1981.tb02789.x

Public

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.

Shared by NobleBlocks on Feb 1, 1981 • 12:00 AM UTC

Authors:

P M Mannucci

M T Canciani

L Rota

Abstract

These studies were designed with the purpose of providing clinico-pharmacological information relevant to the use of DDAVP in the management of mild haemophilia and von Willebrand's disease (VWD). In healthy subjects, intravenous DDAVP produced its maximal response at a dose of 0.3 micrograms/kg. Th...

Discussions